About this trial
Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%.
The aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.
Eligibility criteria
Qualifiers
Major subject (≥18 years old)
Hospitalized between January 1, 2019, and December 31, 2024, in one of the participating centers
Having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center
Disqualifiers
Refusal to participate in the study
Trial design
Treatments tested in this trial
- Not listed